State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases is a research paper published in European Journal of Heart Failure (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph â no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full â never from an abstract alone.
Deutsche Forschungsgemeinschaft
Grant: SFB-1470-A07
Deutsche Forschungsgemeinschaft
Grant: 536819681
Deutsche Krebshilfe
Grant: 70115119
European Research Council
Grant: ERC CoG 101045236
European Research Council
Grant: DISSECT-HF
German Research Foundation
Grant: CRC1366 C07
German Research Foundation
Grant: 394046768
European Union's Horizon 2020 research and innovation programme
Grant: 759248
Endothelial RNA Modifications in Vascular Homeostasis and Disease
British Heart Foundation
Grant: FS/CRTF/21/24175
King's College London BHF Centre of Research Excellence
Grant: RE/18/2/34213
European Commission Horizon 2020 programme
Grant: 825670
CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease
European Commission Horizon 2020 programme
Grant: 874764
New-generation cardiac therapeutic strategies directed to the activation of endogenous regenerative mechanisms
Instituto de Salud Carlos III
Grant: CIBERCV CB16/11/00483
Instituto de Salud Carlos III
Grant: PI21/00946
Norwegian Research council
Grant: #309762
German Center for Cardiovascular Research
Grant: 81Z0500101 and 81X2500195
German Center for Cardiovascular Research
Grant: DZHK-BHF: 81X2600522
Bavarian State Ministry of Health
Grant: DMB-1805â0001
Bavarian State Ministry of Science and the Arts
Grant: 1530/89102
German Federal Ministry of Education and Research
Grant: ZF4590201BA8
Leducq Foundation for Cardiovascular Research
Grant: 20CVD01
Leducq Foundation for Cardiovascular Research
Grant: 18CVD02
Deutsche Forschungsgemeinschaft
Grant: 471241922
Deutsche Forschungsgemeinschaft
Grant: RTG2824-RP4
Deutsche Forschungsgemeinschaft
Grant: SFB-1470-B02
Deutsche Forschungsgemeinschaft
Grant: SFB1366-C07
Italian Ministry of Health
Grant: PNRR-MAD-2022-12376632
Italian Ministry of Health
Grant: RF-2016-02362988
European Union Commission's Seventh Framework programme IMI2-CARDIATEAM
Grant: N° 821508
Dutch Heart Foundation
Grant: 2020-B005
Deutsche Forschungsgemeinschaft
Grant: SFBâ1470âA07
H2020 European Research Council
Grant: DISSECTâHF
Ministero della Salute
Grant: PNRRâMADâ2022â12376632
Ministero della Salute
Grant: RFâ2016â02362988
British Heart Foundation
Grant: RG/19/11/34633
European Research Council
Grant: 101045236
Dynamic engIneered heart tiSsue to Study intEr-individual susCeptibily and improve Treatment of Heart Failure
Bavarian State Ministry of Health
Grant: DMB-1805-0001
European Research Council
Grant: 787971
Cardiac REgeneration from within
European Commission
Grant: 821508
CARdiomyopathy in type 2 DIAbetes mellitus
Deutsche Forschungsgemeinschaft
Grant: 238187445/SFB 1123
Atherosclerosis: Mechanisms and Networks of Novel Therapeutic Targets
The Research Council of Norway
Grant: 309762
ProCardio - Precision Health Center for optimized cardiac care
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
British Heart Foundation
German Federal Ministry of Education and Research (BMBF)
Biotechnology and Biological Sciences Research Council
Deutsches Zentrum fĂŒr Herz-Kreislaufforschung
Innovative Medicines Initiative
German Centre for Cardiovascular Research (DZHK)
German Federal Ministry of Economics and Energy
Health+Life Science Alliance Heidelberg Mannheim GmbH
National Institutes of Health Research
SH receives support of IMI2-CARDIATEAM, from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement N° 821508; the JU receives support from the European Union's Horizon 2020 research and innovation programme.
German Federal Ministry of Education and Research
National Institutes of Health
European Union's Horizon 2020 research and innovation programme
Health+Life Science Alliance Heidelberg Mannheim GmbH and the Biotechnology and Biological Sciences Research Council
FWCI
3.94
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases